<< Previous Section | < Previous Page | Next Page > | Next Section >> Bibliography (page 4 of 5) Kuznik, F. (1998). "Medical Whistle-Blowers." Hippocrates October: 39-47.       This is a very useful article detailing the stories of a number of whistleblowers in cases of medical care and research. It validates the point that as a group they do poorly careerwise but their consciences gave them no choice but to seek the truth. Malakoff, D. (2000). "CLINICAL RESEARCH: Flawed Cancer Study Leads to Shake-Up at University of Oklahoma." Science 289(5480): 706-707.       This news report details the changes in clinical research oversight initiated at the Univ. of Oklahoma in response to findings of terrible sloppiness in carrying out studies. A major vaccine study for cancer was stopped. This was one of the first examples of institutions needing to clean up their research management. Malakoff, D. (2002). "Student Charged with Possessing Anthrax." Science 297(5582): 751-2.       This little news report probably warned everyone who possesses controlled biological agents to follow the law, register the agents and keep them under tight lock and key. Institutions also have to monitor their inventories of these substances and deal very carefully with their transfer. Malakoff, D. (2003). "SCIENTIFIC MISCONDUCT: The Multiple Repercussions of a Fudged Grant Application." Science 300(5616): 40-.       This news report describes the consequences of fudging preliminary work on a research grant and being caught. The allegation from an administrative assistant provoked an investigation and an admission of guilt. The grant still got funded but the investigator was no longer in charge of the program. Beware. Mariner, W. K. (2000). "What Recourse? -- Liability for Managed-Care Decisions and the Employee Retirement Income Security Act." N Engl J Med 343(8): 592-596. Marshall , E. (1995). "Suit Alleges Misuse of Peer Review." Science 270(5244): 1912-4.       When the money is substantial the temptation to use the information that you are supposed to keep confidential may become overwhelming. Be careful, however, you may be sued. An instructive case. Marshall, E. (1999). "SCIENTIFIC ETHICS:Two Former Grad Students Sue Over Alleged Misuse of Ideas." Science 284(5414): 562-563.       This news report deals with allegations that Pis took graduate student's ideas and used them for their own grants. What the investigator did was surely bad manners and perhaps worse but it was not considered to be research misconduct. Could it have been violation of fiduciary responsibility to a mentee? This again emphasizes the unknowns in the relationship between investigators and trainees. Marshall, E. (2000). "SCIENTIFIC MISCONDUCT: How Prevalent Is Fraud? That's a Million-Dollar Question." Science 290(5497): 1662-1663.       This news article reviews estimated misconduct frequency in research. The most striking finding was that one half of students were willing to fake data to get ahead. Investigators claim to know of instances of misconduct, but that has to be taken with a grain of salt. Marshall, E. (2002). "Cancer Study Lawsuit Dismissed in Oklahoma." Science 295(5557): 949-50. Medical Research Law and Policy Report. (2002). Current Climate Fostering More Misconduct, But Education, Monitoring Can Reduce Risks. Bureau of. National Affairs. National Commission for the Protection of Human Subjects of Biomedical and Behavioral Research. (1979). "The Belmont Report: ethical principles and guidelines for the protection of human subjects of research." US Government Printing Office. Normile, D. (2004). "RESEARCH ETHICS: South Korean Cloning Team Denies Improprieties." Science 304(5673): 945-. Pascal, C. (1999). "The History and Future of the Office of Research Integrity: Scientific Misconduct and Beyond." Sci Eng Ethics 5(2): 183-198.       The director of the ORI gives his view of the functioning of the agency in the past and the concerns to which they will be directed in the future. Petersdorf, R. G. (1986). "The Pathogenesis of Fraud in Medical Science." Ann Int Med 104(February): 252-254.       Discussion of fraud in medical science has always been with us. Some of the underlying causes were discussed in this paper, which focuses on hypercompetitiveness, and inadequate supervision and oversight. << Previous Section | < Previous Page | Next Page > | Next Section >> Chapter 8 Quick Links Malfeasance and Misconduct Definitions Process Whistleblowing Litigation, the New Approach to Research Management The Importance of Trust Cases Bibliography Chapter 8 Download (PDF)